Ticker >

Link Pharma Chem share price

Link Pharma Chem Ltd.

BSE: 524748 SECTOR: Pharmaceuticals & Drugs  9184   29   2

44.45
+1.93 (4.54%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 44.6

Today's Low

₹ 42.71

52 Week High

₹ 68.77

52 Week Low

₹ 34.11

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

19.74 Cr.

Enterprise Value

28.3 Cr.

No. of Shares

0.44 Cr.

P/E

0

P/B

1.48

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  30.09

CASH

0.2 Cr.

DEBT

8.76 Cr.

Promoter Holding

51.49 %

EPS (TTM)

₹  -4.09

Sales Growth

-27.64%

ROE

4.43 %

ROCE

7.38%

Profit Growth

-65.23 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-27.64%
3 Year15.02%
5 Year10.49%

Profit Growth

1 Year-65.23%
3 Year-11.69%
5 Year-10.43%

ROE%

1 Year4.43%
3 Year9.13%
5 Year8.53%

ROCE %

1 Year7.38%
3 Year12.51%
5 Year12.14%

Debt/Equity

0.5823

Price to Cash Flow

-11.56

Interest Cover Ratio

2.1646517739816

CFO/PAT (5 Yr. Avg.)

1.18502804261347

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 51.49 0
Dec 2023 51.49 0
Sep 2023 51.49 0
Jun 2023 51.49 0
Mar 2023 51.49 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 15.0192913182648% for the Past 3 years.
  • Company’s PEG ratio is 0.166525944192086.
  • The company has an efficient Cash Conversion Cycle of 27.3285308335188 days.
  • The company has a high promoter holding of 51.49%.

 Limitations

  • The company has shown a poor profit growth of -11.6887152533956% for the Past 3 years.
  • Company has negative cash flow from operations of -1.7069.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 9.36 9.29 7.88 6.05 7.94
Total Expenditure 8.72 9.01 8.84 6.94 7.66
Operating Profit 0.65 0.28 -0.96 -0.89 0.28
Other Income 0.08 -0.03 0.31 -0.03 0.37
Interest 0.19 0.26 0.23 0.22 0.23
Depreciation 0.24 0.23 0.26 0.26 0.27
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.3 -0.23 -1.14 -1.39 0.15
Tax 0.12 -0.04 -0.32 -0.37 -0.07
Profit After Tax 0.18 -0.19 -0.82 -1.02 0.22
Adjusted EPS (Rs) 0.4 -0.43 -1.86 -2.3 0.5

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 24.5 25.47 34.81 53.56 38.76
Total Expenditure 22.48 22.87 31.85 50.36 36.45
Operating Profit 2.02 2.6 2.97 3.2 2.31
Other Income 0.19 0.13 0.03 0.8 0.26
Interest 0.39 0.36 0.44 0.45 0.76
Depreciation 0.89 0.93 0.87 0.93 0.92
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.93 1.44 1.68 2.62 0.89
Tax 0.27 0.49 0.59 0.74 0.23
Net Profit 0.66 0.95 1.08 1.88 0.65
Adjusted EPS (Rs.) 1.48 2.14 2.44 4.24 1.47

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 4.44 4.44 4.44 4.44 4.44
Total Reserves 5.94 6.99 8.12 10.03 10.6
Borrowings 1.71 3.17 3.16 2.9 1.98
Other N/C liabilities 1.04 0.91 1.04 0.98 0.92
Current liabilities 4.88 3.45 9.28 10.61 14.51
Total Liabilities 18 18.97 26.04 28.96 32.46
Assets
Net Block 9.14 8.81 8.71 8.79 9
Capital WIP 0.43 0 0 0.21 0
Intangible WIP 0 0 0 0 0
Investments 0.03 0.03 0.03 4.52 3.64
Loans & Advances 1.2 0.98 2.09 1.73 1.66
Other N/C Assets 0.02 0.07 0.07 0.15 0.61
Current Assets 7.18 9.08 15.14 13.57 17.55
Total Assets 18 18.97 26.04 28.96 32.46
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.93 1.44 1.68 2.62 0.89
Adjustment 1.26 2.04 1.46 0.96 2.25
Changes in Assets & Liabilities -0.63 -0.64 2.18 -4.16 -4.43
Tax Paid -0.2 0.11 -0.48 -0.67 -0.41
Operating Cash Flow 1.36 2.95 4.84 -1.26 -1.71
Investing Cash Flow -0.96 -1.66 -2.16 -4.97 -0.08
Financing Cash Flow -0.46 0.55 -0.33 2.27 1.61
Net Cash Flow -0.05 1.85 2.35 -3.95 -0.17

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 51.49 51.49 51.49 51.49 51.49
maya satish thakur 15.55 15.55 15.55 15.55 15.55
rishikesh satishbhai thak... 14.11 14.11 14.11 14.11 14.11
satish ganpatrao thakur 14.91 14.91 14.91 14.91 14.91
shriniwas vasantrao thaku... 2.09 2.09 2.09 2.09 2.09
sonia rajesh wani - - 4.83 4.83 4.83
sonia satish thakur 4.83 4.83 - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 48.51 48.51 48.51 48.51 48.51
berazman hormazd doctor - - 1.25 1.68 1.83
chirayu jayesh shah (huf)... - - - 1.40 1.09
daksha vishanji kotak - - - 1.87 1.87
gurudev marketing pvt. lt... 5.76 5.76 5.76 5.76 5.76
llp 0.01 0.01 0.01 0.01 0.01
kotak daksha vishanji 1.87 1.87 1.87 - -
nirmaladevi sanjay agarwa... 1.15 1.15 1.15 - -
deepinder singh poonian 1.65 - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Link Pharma Chem informs about issuance of letter of confirmation23 Apr 2024, 4:52PM Link Pharma Chem informs about details of loss of certificate 1 Apr 2024, 5:13PM Link Pharma Chem informs about closure of trading window 27 Mar 2024, 4:44PM Link Pharma Chem informs about sale of unutilized office located at Vadodara 14 Mar 2024, 4:34PM Link Pharma Chem informs about newspaper advertisements12 Feb 2024, 1:30PM Link Pharma Chem - Quaterly Results9 Feb 2024, 2:58PM Link Pharma Chem - Quaterly Results9 Feb 2024, 2:58PM Link Pharma Chem - Quaterly Results9 Feb 2024, 2:58PM Link Pharma Chem informs about loss of share certificates29 Jan 2024, 5:23PM Link Pharma Chem informs about board meeting 31 Oct 2023, 5:15PM Link Pharma Chem informs about loss of share certificate(s)20 Oct 2023, 1:07PM Link Pharma Chem informs about details of loss of certificate 23 Sep 2023, 11:44AM Link Pharma Chem informs about unaudited financial results 14 Aug 2023, 4:25PM Link Pharma Chem - Quaterly Results14 Aug 2023, 3:06PM Link Pharma Chem informs about details of loss of certificate 5 May 2023, 1:01PM Link Pharma Chem informs about issuance of letter of confirmation17 Apr 2023, 11:55AM Link Pharma Chem - Quaterly Results9 Feb 2023, 2:43PM Link Pharma Chem - Quaterly Results9 Feb 2023, 2:43PM Link Pharma Chem - Quaterly Results9 Feb 2023, 2:43PM Link Pharma Chem informs about closure of trading window27 Sep 2022, 4:31PM Link Pharma Chem informs about resignation of CS cum CO16 Sep 2022, 4:26PM Link Pharma Chem informs about loss of share certificate16 Jul 2022, 11:58AM Link Pharma Chem informs about newspaper advertisements14 Jul 2022, 1:01PM Link Pharma Chem informs about newspaper publications31 May 2022, 1:08PM Link Pharma Chem informs about non- applicability of large corporate entity11 May 2022, 1:00PM Link Pharma Chem informs about compliance certificate8 Apr 2022, 4:55PM Link Pharma Chem informs about disclosure2 Apr 2022, 11:42AM Link Pharma Chem informs about closure of trading window24 Mar 2022, 11:36AM Link Pharma Chem informs about certificate6 Oct 2021, 3:39PM Link Pharma Chem informs about compliance certificate3 Jul 2021, 2:06PM Link Pharma Chem informs about closure of trading window26 Jun 2021, 3:57PM Link Pharma Chem informs about certificate5 Apr 2021, 4:05PM Link Pharma chem informs about certificate4 Jan 2021, 3:29PM Link Pharma Chem informs about closure of trading window28 Dec 2020, 10:46AM Link Pharma Chem informs about 35th AGM notice26 Aug 2020, 4:36PM

Link Pharma Chem Stock Price Analysis and Quick Research Report. Is Link Pharma Chem an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Link Pharma Chem and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Link Pharma Chem cash from the operating activity was Rs -1.7069 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Link Pharma Chem has a Debt to Equity ratio of 0.5823 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Link Pharma Chem , the EPS growth was -65.2342182890855 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Link Pharma Chem has OPM of 5.96138067692182 % which is a bad sign for profitability.
     
  • ROE: Link Pharma Chem have a poor ROE of 4.43316538986715 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Link Pharma Chem is Rs 44.59. One can use valuation calculators of ticker to know if Link Pharma Chem share price is undervalued or overvalued.
Last Updated on:
Brief about Link Pharma Chem
X